Top broker: The Bubs (ASX:BUB) share price has more than 20% upside

Citi thinks there's plenty of upside for Bubs.

| More on:
Two babies laying down together drink milk made with Bubs infant formula in bottles as the Bubs share price rises again today

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price has more than 20% upside from where it is today.

Bubs is one of the leading Australian infant nutrition businesses with a number of products including goat infant formula, organic grass-fed cow infant formula, organic infant snacks, and vitamins.

Broker's bullish rating for the Bubs share price

Whilst Bubs shares have declined by 27% over the past year, a top broker thinks it can make a good recovery.

Citi has a price target on the business of $0.58, which is currently 23% higher than where it is right now. The broker thinks that the outlook is improving for Bubs and that the business can expand geographically and launch new products.

Bubs' recovery

In the first quarter of FY22, total gross revenue nearly doubled to $18.5 million. This was growth of 96% year on year and 45% quarter on quarter.

Management said that the revenue growth was achieved across its key business segments, overcoming COVID-19 disruptions and a challenging macro environment.

The higher margin Bubs infant formula gross revenue increased 124% year on year and went up 64% quarter on quarter.

Bubs was particularly pleased with the level of growth with its China-facing businesses, total revenue here went up 156% year on year and 98% quarter on quarter. Infant formula daigou sales rose 648% year on year and 265% quarter on quarter. Cross-border e-commerce sales rose 49% year on year and 19% quarter on quarter.

Its global expansion strategy is advancing with established entities in New Zealand, China and the USA.

International revenue, outside of China, experienced growth of 489% year on year and made up 24% of quarterly sales. Export sales of Bubs infant formula to markets outside of China went up 154%.

Bubs is also ramping up its business to business services with Deloraine Dairy Solutions, with the aim of being a specialist dairy solution for co-manufacturing and end to end product development for global customers. It contributed 17% of FY22 first quarter revenue (a 16-fold increase year on year).

Outlook

Investors often take into account the outlook for a business, so the Bubs outlook could influence the Bubs share price.

The company wants to grow in numerous countries and regions outside of Australia and China, including Vietnam, Malaysia, Singapore, USA, Europe, the Middle East and Africa.

The Bubs executive chair Dennis Lin said:

We continue to explore opportunities to stretch the Bubs brand to cater to new market segments, adjacent categories and consumer groups.

In light of that, we are confident that our vision to take Bubs to a global stage is becoming a reality…having recovered the ground lost due to COVID-19 disruption, we expect to be able to sustain continued growth momentum, to the extent our forward approach does not depend on a material improvement in the pandemic setting.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors started the week off in a good mood today.

Read more »

A cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.
Broker Notes

Up 37% this year, why Macquarie expects A2 Milk shares to keep outperforming

Macquarie remains bullish on A2 Milk shares heading into 2026. Let’s see why.

Read more »

Woman and man calculating a dividend yield.
Share Market News

Big week for markets: Here's what to watch

Tech earnings, rate speculation, and Aussie inflation data could shake markets this week — but long-term investors should keep their…

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

dissapointed man at falling share price
Share Fallers

Why Boss Energy, Elsight, Pilbara Minerals, and Whitehaven Coal shares are falling today

These shares are starting the week in the red. But why?

Read more »

An older female ASX investor holds a gangster-style fist pump pose showing off gold rings with dollar signs on them.
Broker Notes

Why Macquarie forecasts Northern Star shares are set to surge 55%

Macquarie believes Northern Star shares are well-placed to rocket higher.

Read more »

A group of people gathered around a laptop computer with various expressions of interest, concern and surprise on their faces. All are wearing glasses.
Share Market News

ASX 200 tech stock near record high, is it still a buy?

This company's soaring share price and rising profits are turning heads.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Bellevue Gold, Bubs, Clarity Pharmaceuticals, and Regal Partners shares are rising today

These shares are starting the week on a positive note.

Read more »